Zheng Yanfang, Zhang Jiren, Qu Lianghu
Department of Oncology, Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China.
Chin Med J (Engl). 2002 Oct;115(10):1501-6.
To investigate the effects of anti-HPV16E6-ribozyme (HRz) on phenotype and gene expression of a cervical cancer cell line.
HRz was designed by computer programs. HRz's activity was identified by cleavage experiments in vitro. HRz and empty eukaryotic plasmids were transfected into CaSKi cells with lipofectin, then renamed CaSKi-R and CaSKi-P, respectively. The expression of ribozyme in transfected cells was observed by RNA dot blot. The amounts of E6 mRNA in three kinds of cells lines were detected by Northern blot. Cell growth curves and soft agar forming ability were studied. The ability of each cell line to form tumors was assessed in nude mice. Apoptosis rates and expression of c-myc, bcl-2, p53 and Fas were detected by flow cytometry (FCM). Antigens of tumor cells, HLA-1, HLA-2, B7-1 and B7-2 were also detected. NK, LAK, and CD(3)AK cells were induced. Their cytotoxicities were detected in CaSKi-R, CaSKi-P, and CaSKi cells.
In vitro cleavage reaction demonstrated that HRz could cleave HPV16E6 mRNA in a site-specific manner. HRz could be expressed stably in transfected CaSKi cells. Northern blot analysis showed that E6 mRNA levels were lower in CaSKi-R than in CaSKi. The growth rate of CaSKi-R was slower than those of CaSKi and CaSKi-P. The soft agar-forming rate of CaSKi-R was lower compared with those of CaSKi and CaSKi-P cells. The ability of CaSKi-R to form tumors in nude mice was also poor. The apoptosis rate of CaSKi-R cells was much higher than those of CaSKi and CaSKi-P. HRz could reduce the expression of E6, c-myc and bcl-2 proteins, and increase the expression of p53 as well. HRz could increase the expression of HLA-2, B7-1 and B7-2 antigens. The cytotoxicity of NK, LAK and CD(3)AK cells was much higher in CaSKi-R than in CaSKi-P and CaSKi cells.
HRz not only reverses the malignant phenotype of CaSKi cells partially, but also induces apoptosis in the cells, and increases sensitivity of CaSKi cells to immune cells.
研究抗人乳头瘤病毒16E6核酶(HRz)对宫颈癌细胞系表型及基因表达的影响。
利用计算机程序设计HRz。通过体外切割实验鉴定HRz的活性。用脂质体将HRz和空真核质粒分别转染入CaSKi细胞,转染后的细胞分别命名为CaSKi-R和CaSKi-P。采用RNA斑点杂交观察转染细胞中核酶的表达情况。用Northern杂交检测三种细胞系中E6 mRNA的含量。研究细胞生长曲线及软琼脂形成能力。在裸鼠体内评估各细胞系的成瘤能力。采用流式细胞术(FCM)检测凋亡率及c-myc、bcl-2、p53和Fas的表达。检测肿瘤细胞的HLA-1、HLA-2、B7-1和B7-2抗原。诱导NK、LAK和CD(3)AK细胞,检测它们对CaSKi-R、CaSKi-P和CaSKi细胞的细胞毒性。
体外切割反应表明,HRz能以位点特异性方式切割HPV16E6 mRNA。HRz能在转染的CaSKi细胞中稳定表达。Northern杂交分析显示,CaSKi-R细胞中E6 mRNA水平低于CaSKi细胞。CaSKi-R细胞的生长速度慢于CaSKi和CaSKi-P细胞。与CaSKi和CaSKi-P细胞相比,CaSKi-R细胞的软琼脂形成率较低。CaSKi-R细胞在裸鼠体内的成瘤能力也较差。CaSKi-R细胞的凋亡率远高于CaSKi和CaSKi-P细胞。HRz可降低E6、c-myc和bcl-2蛋白的表达,同时增加p53的表达。HRz可增加HLA-2、B7-1和B7-2抗原的表达。CaSKi-R细胞对NK、LAK和CD(3)AK细胞的细胞毒性远高于CaSKi-P和CaSKi细胞。
HRz不仅能部分逆转CaSKi细胞的恶性表型,还能诱导细胞凋亡,增加CaSKi细胞对免疫细胞的敏感性。